Orchid Pharma Ltd. benchmarking: Performance to industry peers

Financial

	Orchid Pharma	Bliss GVS Pharma	Gufic Biosciences
Operational Metrics
Financials
5 yr Average ROE	4.49 %	6.83 %	16.89 %
5yr average Equity Multiplier	1.61	1.3	2.16
5yr Average Asset Turnover Ratio	0.5	0.62	0.75
5yr Avg Net Profit Margin	0.56 %	8.7 %	10.24 %
Price to Book	2.23	2.42	4.79
P/E	150.33	25.08	60.36
5yr Avg Cash Conversion Cycle	52.03 Days	186.56 Days	-15.25 Days
Inventory Days	112.47 Days	54.35 Days	71.73 Days
Days Receivable	86.58 Days	189.93 Days	106.89 Days
Days Payable	159.29 Days	75.78 Days	179.29 Days
5yr Average Interest Coverage Ratio	3.01	14.68	8.9
5yr Avg ROCE	3.08 %	13.27 %	17.89 %
5yr Avg Operating Profit Margin	11.84 %	17.03 %	18.12 %
5 yr average Debt to Equity	0.37	0.11	0.67
5yr CAGR Net Profit	n/a	4.24 %	-2.66 %
5yr Average Return on Assets	1.2 %	5.31 %	7.7 %
Shareholdings
Promoter Holding	69.84 %	35.36 %	72.5 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-20.12 %	0.9 %	-2.5 %
Change in Mutual Fund Holding (3 Yrs)	15.56 %	0.0	2.5 %

Business

	Orchid Pharma	Bliss GVS Pharma	Gufic Biosciences
Product Wise Break-Up	Product Wise Break-Up Oral Formulations 72.44 Sterile 27.56 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0	Product Wise Break-Up Anti-bacterials 0 Muscle Relaxants 0 Oral Formulations 0 CMO 0 Proton pump inhibitors 0 Anti-fungal 16.0 Domestic 0 Anti-fungals 0 Anti-bacterial 0 Anti Malarials 43.0 Sterile 0 Antibiotics 5.0 Anti Inflammatory 7.0 International 0 API 0 Cardiovascular 0 Others 29.0	Product Wise Break-Up Anti-bacterials 0 Muscle Relaxants 0 Oral Formulations 0 CMO 30.0 Proton pump inhibitors 0 Anti-fungal, 0 Domestic Pharmaceuticals 50.0 Anti-fungals 0 Anti-bacterial 0 Antimalarial 0 Sterile 0 Anti-biotic 0 Anti Inflammatory 0 International 15.0 Active Pharmaceutical Ingredient (API) 5.0 Cardiovascular 0
Location Wise Break-Up	Location Wise Break-Up India 19.9 Rest of the World 0 South America 0 Australia 0 North America 0 Europe 0 Asia 0 Africa 0 Others 80.1	Location Wise Break-Up North America 0 Africa 0 Asia 0 Europe 0 Australia 0 India 6.61 South America 0 Rest of the World 93.39	Location Wise Break-Up North America 1.19 Africa 2.95 Asia Pacific 6.04 Europe 7.54 Australia 0.08 India 79.83 South America 2.37 Rest of the World 0
Asset Break-Up - Geography Wise	Asset Break-Up - Geography Wise Others 100	-	-

Orchid Pharma Ltd.

Orchid Pharma Ltd.

Financial

Business

SIGN UP FOR FREE